Inspire Medical Systems (INSP) Stock Price, News & Analysis

14 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Inspire Medical Systems in the last twelve months. There are currently 4 hold ratings and 10 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" INSP shares.
View INSP analyst ratings or view top-rated stocks.

14 equities research analysts have issued 12 month target prices for Inspire Medical Systems' shares. Their INSP share price targets range from $159.00 to $371.00. On average, they predict the company's share price to reach $272.20 in the next twelve months. This suggests a possible upside of 18.7% from the stock's current price.
View analysts price targets for INSP or view top-rated stocks among Wall Street analysts.

Inspire Medical Systems' stock was trading at $203.43 at the beginning of 2024. Since then, INSP shares have increased by 12.7% and is now trading at $229.26.
View the best growth stocks for 2024 here.

Inspire Medical Systems saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 2,080,000 shares, an increase of 11.2% from the March 15th total of 1,870,000 shares. Based on an average trading volume of 488,200 shares, the days-to-cover ratio is currently 4.3 days.
View Inspire Medical Systems' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 7th 2024.
View our INSP earnings forecast.

Inspire Medical Systems will be holding an earnings conference call on Tuesday, May 7th at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link.

Inspire Medical Systems, Inc. (NYSE:INSP) released its quarterly earnings results on Tuesday, February, 6th. The company reported $0.49 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.04) by $0.53. The company earned $192.51 million during the quarter, compared to analyst estimates of $186.75 million. Inspire Medical Systems had a negative trailing twelve-month return on equity of 3.93% and a negative net margin of 3.39%. The business's revenue was up 39.6% compared to the same quarter last year. During the same period last year, the business posted $0.10 earnings per share.

ETFs with the largest weight of Inspire Medical Systems (NYSE:INSP) stock in their portfolio include First Trust Nasdaq Lux Digital Health Solutions ETF (EKG), Harbor Health Care ETF (MEDI), Fidelity Digital Health ETF (FDHT), Fidelity Disruptive Medicine ETF (FMED), BNY Mellon Innovators ETF (BKIV), SPDR S&P Health Care Equipment ETF (XHE), WisdomTree U.S. Growth & Momentum Fund (WGRO) and Principal Healthcare Innovators ETF (BTEC).

Inspire Medical Systems issued an update on its FY 2024 earnings guidance on Tuesday, February, 27th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $775.0 million-$785.0 million, compared to the consensus revenue estimate of $780.3 million.

2 employees have rated Inspire Medical Systems Chief Executive Officer Tim Herbert on Glassdoor.com. Tim Herbert has an approval rating of 100% among the company's employees. This puts Tim Herbert in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Inspire Medical Systems investors own include Advanced Micro Devices (AMD), NVIDIA (NVDA), Cisco Systems (CSCO), Bank of America (BAC), DocuSign (DOCU), Pfizer (PFE), Block (SQ), Zynga (ZNGA), CrowdStrike (CRWD) and Johnson & Johnson (JNJ).

Inspire Medical Systems (INSP) raised $75 million in an initial public offering (IPO) on Thursday, May 3rd 2018. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. BofA Merrill Lynch and Goldman Sachs served as the underwriters for the IPO and Guggenheim Securities, Stifel and Wells Fargo Securities were co-managers.

Inspire Medical Systems' stock is owned by a number of institutional and retail investors. Top institutional investors include Wasatch Advisors LP (3.64%), Allspring Global Investments Holdings LLC (0.55%), Rheos Capital Works Inc. (0.26%), Congress Asset Management Co. MA (0.05%), Massmutual Trust Co. FSB ADV (0.05%) and Private Ocean LLC (0.04%). Insiders that own company stock include Georgia Melenikiotou, Jerry C Griffin, John Rondoni, Marilyn C Nelson, Philip Ebeling, Randy Ban, Richard Buchholz, Steven Jandrich and Timothy P Herbert.
View institutional ownership trends.

Shares of INSP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.